NDC11 16571011210
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 16571-0112-10 | 16571-0112 |
| 16571-112-10 | 16571-112 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydroxychloroquine Sulfate | HYDROXYCHLOROQUINE SULFATE | Rising Pharma Holdings, Inc. | 6837f2aa-1349-4b45-a0ac-09ec914fd764 | 2024-05-06 | Warnings, Adverse reactions | 16571-112-10 16571-112 16571011210 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.